Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00512278 · ClinicalTrials.gov registry record · Phase 2

Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C

A Phase 2 study of Hepatitis C, sponsored by Nizar Zein.

Completed
Registry status
Phase 2
Development phase
146
Enrollment target
7
Study locations

NCT00512278 is a Phase 2 study of Hepatitis C that has completed, run by Nizar Zein. The registered enrollment target is 146 participants, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00512278, a Phase 2 study of Hepatitis C, has completed, sponsored by Nizar Zein.

COMPLETED
Registry status
Phase 2
Development phase
146 participants
Enrollment target
7
Study locations

Study Summary

The aim of the study is to investigate in subjects receiving their first course of peg-interferon α-2b plus ribavirin therapy for chronic HCV infection

Conditions Studied

Hepatitis C

Interventions

  • DRUG Placebo
  • DRUG Infliximab

Study Locations (7)

Ohio

  • Case Medical Center - Cleveland
  • Cleveland Clinic - Cleveland

Texas

  • The Liver Institute at Methodist Dallas - Dallas
  • Brooke Army Medical Center - San Antonio

California

  • Cedars-Sinai Medical Center, Center for Liver Disease and Transplantation - Los Angeles

Florida

  • Advanced Medical Research Center - Port Orange

Kentucky

  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2007-07
Est. Completion 2012-05
Phase Phase 2

Sponsor

Nizar Zein

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00512278

The ClinicalTrials.gov registry entry for NCT00512278 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,889-participant average among 106 other Hepatitis C trials with a reported enrollment target (92% lower). The listed sponsor is Nizar Zein, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00512278 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Ohio, Texas, California.

Frequently Asked Questions

What is clinical trial NCT00512278 about?

NCT00512278 is a clinical study titled "Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C". The aim of the study is to investigate in subjects receiving their first course of peg-interferon α-2b plus ribavirin therapy for chronic HCV infection

What is the current status of trial NCT00512278?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2007-07. Estimated completion is 2012-05.

What conditions does trial NCT00512278 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT00512278?

The interventions under investigation include: Placebo (DRUG), Infliximab (DRUG).

Who is sponsoring clinical trial NCT00512278?

This trial is sponsored by Nizar Zein, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00512278 being conducted?

This trial has 7 study locations across California, Florida, Kentucky, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.